Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: Linkage study of the candidate genes NRAMP1 and TNFA

Tubercle and Lung Disease

Volumn 78, Issue 1, 1997, Pages 35-45

  Shaw, M A ^a,b   Collins, A ^c   Peacock, C S ^a   Miller, E N ^a   Black, G F ^a   Sibthorpe, D ^a   Lins Lainson, Z ^d   Shaw, J J ^f   Ramos, F ^f   Silveira, F ^d   Blackwell, J M ^a,e  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c PRINCESS ANNE HOSPITAL   (United Kingdom)

^d INSTITUTO EVANDRO CHAGAS   (Brazil)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CHILD; COMPUTER ANALYSIS; COMPUTER MODEL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FAMILY; FEMALE; GENE CLUSTER; GENE CONTROL; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MODEL; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; HUMAN; HYPOTHESIS; INFANT; INHERITANCE; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PEDIGREE ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; SEGREGATION ANALYSIS; STATISTICAL ANALYSIS; TUBERCULOSIS;

EID: 13144267758     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8479(97)90014-9     Document Type: Article

References (74)

1. Stead W W, Senner J W, Reddick W T, Lofgren J P. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 1990; 322: 422-427.
2. Simonds B. Tuberculosis in twins. London: Pitman Medical, 1963.
3. Kallmann F J, Reisner D. Twin studies on the significance of genetic factors in Tuberculosis. Am Rev Tuberculosis 1943; 47: 549-574.
4. Comstock G W. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 1978; 117: 621-624.
5. Fine P E M. Immunogenetics of susceptibility to leprosy, tuberculosis, and leishmaniasis. An epidemiological perspective. Int J Lepr 1981; 49: 437-454.
6. Blackwell J M. Bacterial infections. In: Wakelin D, Blackwell J M, eds. Genetics of resistance to bacterial and parasitic infection. London: Taylor & Francis, 1988: 63-101.
7. Newport M J, Blackwell J M. Genetic susceptibility to tuberculosis. Bailliere's clinical infectious diseases: mycobacterial disease 1997; 4: 207-230.
8. Haile R W C, Iselius L, Fine P E M, Morton N E. Segregation and linkage analysis of 72 leprosy pedigrees. Hum Hered 1985; 35: 43-52.
9. Shields E D, Russell D A, Pericak-Vance M A. Genetic epidemiology of the susceptibility to leprosy. J Clin Invest 1987; 79: 1139-1143.
10. Abel L, Demenais F. Detection of major genes for susceptibility to leprosy and its subtypes in a Caribbean island: Desirade Island. Am J Hum Genet 1988; 42: 256-266.
11. Feitosa M F, Borecki I, Krieger H, Beiguelman B, Rao D C. The genetic epidemiology of leprosy in a Brazilian population. Am J Hum Genet 1995; 56: 1179-1185.
12. Abel L, Vu D L, Oberti J et al. Complex segregation analysis of leprosy in southern Vietnam. Genet Epidemiol 1995; 12: 63-82.
13. Lune M B. Resistance to tuberculosis: experimental studies in native and acquired defensive mechanisms. Cambridge: Harvard University Press, 1964.
14. Gros P, Skamene E, Forget A. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol 1981; 127: 2417-2421.
15. Forget A, Skamene E. Genetic regulation of early host defense mechanisms controlling mycobacterial infection. Prog Leuk Biol 1985; 3: 265-277.
16. Goto Y, Nakamura R M, Takahashi H, Tokunaga T. Genetic control of resistance to Mycobacterium intracellulare infection in mice. Infect Immun 1984; 46: 135-140.
17. Brown I N, Glynn A A, Plant J. Inbred mouse strain resistance to Mycobacterium lepraemurium follows the Ity/Lsh pattern. Immunology 1982; 47: 149-156.
18. Skamene E, Gros P, Forget A, Patel P J, Nesbitt M N. Regulation of resistance to leprosy by chromosome 1 locus in the mouse. Immunogenetics 1984; 19: 117-124.
19. Goto Y, Buschman E, Skamene E. Regulation of host resistance to Mycobacterium intracellulare in vivo and in vitro by the Bcg gene. Immunogenetics 1989; 30: 218-221.
20. r) develop a superior capacity to stabilize bacille Calrnette-Guerin (BCG) infections in their lungs and spleen over a protracted period in the absence of specific immunity. Clin Exp Immunol 1996; 104: 44-47.
21. Orme. Only two out of fifteen BCG strains follow the Bcg pattern. Prog Leuk Biol 1985; 3: 285-289.
22. Medina E, North RJ. Evidence inconsistent with a role for the Bcg gene (Nrampl) in resistance of mice to infection with virulent Mycobacterium tuberculosis. J Exp Med 1996; 183: 1045-1051.
23. Medina E, North R A. The Bcg gene (Nramp1) does not determine resistance of mice to virulent Mycobacterium tuberculosis. Ann N Y Acad Sci 1996; 797: 257-259.
24. Medina E, Rogerson B J, North R A. The Nramp1 antimicrobial resistance gene segregates independently of resistance to virulent Mycobacterium tuberculosis. Immunology 1996; 88: 479-481.
25. White J K, Shaw M-A, Barton C H et al. Genetic and physical mapping of 2q35 in the region of NRAMP and IL8R genes: identification of a polymorphic repeat in exon 2 of NRAMP. Genomics 1994; 24: 295-302.
26. Shaw M-A, Atkinson S, Dockrell H et al. An RFLP map for 2q33-q37 from multicase mycobacterial and leishmanial disease families: no evidence for an Lsh/Ity/Bcg gene homologue influencing susceptibility to leprosy. Ann Hum Genet 1993; 57: 251-271.
27. Blackwell J M, Barton C H, White J K et al. Genomic organization and sequence of the human NRAMP gene: identification and mapping of a promoter region polymorphism. Mol Med 1995; 1: 194-205.
28. Iiu J, Fujiwara T M, Buu N T et al. Identification of polymorphisms and sequence variants in human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet 1995; 56: 845-853.
29. Buu N T, Cellier M, Gros P, Schurr E. Identification of a highly polymorphic length variant in the 3′UTR of NRAMP1. Immunogenetics 1995; 42: 428-429.
30. Lewis L-A, Victor T, Hoal-van Helden E et al. Identification of a C to T mutation at position -236bp in the human NRAMP1 promoter. Immunogenetics 1996; 44: 309-311.
31. Abel L, Sanchez F, Thuc N V et al. Linkage of leprosy to the human NRAMP1 gene in Vietnamese families. Braz J Genet 1996; 19: 113.
32. Adu H O, Curtis J, Turk J L Role of the major histocompatibility complex in resistance and granuloma formation in response to Mycobacterium lepraemurium infection. Infect Immun 1983; 40: 720-725.
33. Brett S J, Orrell J, Swanson Beck J, Ivanyi J. Influence of H-2 genes on growth of Mycobacterium tuberculosis in the lungs of chronically infected mice. Immunology 1992; 76: 129-132.
34. Apt A S, Avdienko V G, Nikonenko IB, Kramnik IB, Moroz A M, Skamene E. Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice. Clin Exp Immunol 1993; 94: 322-329.
35. Campbell R D, Trowsdale J. Map of the human MHC. Immunol Today 1993; 14: 349-352.
36. Trowsdale J. Genomic structure and function in the MHC. Trends Genet 1993; 9: 117-122.
37. McGuire W, Hill A S V, Allsop C E M, Greenwood B M, Kwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-511.
38. Cabrera M, Shaw M-A, Sharples C et al. Polymorphism in TNF genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182: 1259-1264.
39. Rook G A, Taverne J, Leveton C, Steele J. The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology 1987; 62: 229-234.
40. Filley E A, Bull H A, Dowd P M, Rook G A. 'The effect of Mycobacterium tuberculosis on the susceptibility of human cells to the stimulatory and toxic effects of tumour necrosis factor. Immunology 1992; 77: 505-509.
41. Chan J, Xing Y, Magliozzo R S, Bloom B R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992; 175: 1111-1122.
42. Denis M. 'Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol 1996; 49: 380-387.
43. Blackwell J M, Black G F, Peacock C S et al. Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study. Phil Trans R Soc Lond B 1997; 352: 1321-1345.
44. Lalouel J M, Morton N E. Complex segregation analysis with pointers. Hum Hered 1981; 31: 312-321.
45. Morton N E, Shields D C, Collins A. Genetic epidemiology of complex phenotypes. Ann Hum Genet 1991; 55: 301-314.
46. Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control 1974; 19: 716-723.
47. Morton N E, Rao D C, Lalouel J-M. Methods in genetic epidemiology. Basel: Karger, 1983.
48. Shields D C, Collins A, Marlow A. Coding of pointers in the segregation analysis program POINTER Genet Epidemiol 1994; 11: 385-387.
49. Copeman J B, Cucca C, Hearne C M et al. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDMT) to chromosome 2q31-q33. Nature Genet 1995; 9: 80-85.
50. Wilson A G, di Giovine F S, Blakemore A I F, Duff G W. Single base polymorphism in the human tumour necrosis factor alpha (TNFa) gene detectable by Nco1 restriction of PCR product. Hum Mol Genet 1993; 1: 353.
51. Messer G, Spengler U, Jung M C et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-b gene correlates with a variant amino acid in position 26 and a reduced level of TNF-b production. J Exp Med 1991; 173: 209-219.
52. Jongenell C V, Briant L, Udalova I A, Sevin A, Nedospasov S A, Cambon-Thomsen A. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci USA 1991; 88: 9717-9721.
53. Holmans P, Clayton D. Efficiency of typing unaffected relatives in an affected sib-pair linkage study with single locus and multiple tightly-linked markers. Am J Hum Genet 1995; 57: 1221-1232.
54. Morton N E. Logarithm of odds (Lods) for linkage in complex inheritance. Proc Natl Acad Sci USA 1996; 93: 3471-3476.
55. Lio P, Morton N E. Comparison of parametric and nonparametric methods to map oligogenes by linkage. Proc Natl Acad Sci USA 1997; 94: 5344-5348.
56. Morton N E. Sequential tests for the detection of Linkage. Am J Hum Genet 1955; 7: 277-318.
57. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genet 1995; 11: 241-247.
58. Demenais F, Lathrop M. REGRESS: a computer program including the regression approach into the LINKAGE package. Genet Epidemiol 1994; 11: 291.
59. Davies J L, Kawaguchi Y, Bennett S T et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371: 130-136.
60. John S, Hajeer A, Marlow A et al. Investigation of candidate disease susceptibility genes in rheumatoid arthritis. J Rheumatol 1997; 24: 199-201.
61. Ott J. Analysis of human genetic linkage. Baltimore: Johns Hopkins University Press, 1991.
62. Tomlinson IP, Bodmer W F. The HLA system and the analysis of multifactorial genetic disease. Trends Genet 1995; 11: 493-498.
63. Singh S P, Mehra N K, Dingley H B, Pande J N, Vaidya M C. Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. J Infect Dis 1983; 148: 676-681.
64. Singh S P, Mehra N K, Dingley H B, Pande J N, Vaidya M C. HLA haplotype segregation study in multiple case families of pulmonary tuberculosis. Tissue Antigens 1984; 23: 84-86.
65. de Vries R R P, Fat R F M L A, Nijenhuis L E, van Rood J J. HLA-linked genetic control of host response to Mycobacterium leprae. Lancet 1976; ii: 1328-1330.
66. Fine P E, Wolf E, Pritchard J et al. HLA-linked genes and leprosy: a family study in Karigiri, South India. J Infect Dis 1979; 140: 152-161.
67. Van Eden W, Gonzalez N M, de Vries R R P, Convit J, van Rood JJ. HLA linked control of predisposition to lepromatous leprosy. J Infect Dis 1985; 151: 9-14.
68. Blackwell J M. The macrophage resistance gene Lsh/Ity/Bcg. Res Immunol 1989; 140: 767-828.
69. Blackwell J M. Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious and autoimmune disease susceptibility. Mol Med Today 1996; 2: 205-211.
70. Blackwell J M, Roach TIA, Atkinson S E, Ajioka J W, Barton C H, Shaw M-A. Genetic regulation of macrophage priming/ activation: the Life gene story. Immunol Lett 1991; 30: 241-248.
71. Blackwell J M, Barton C H, White J K et al. Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. Immunol Lett 1994; 43: 99-107.
72. Skamene E. The Bcg gsne story. Immunobiology 1994; 191: 451-460.
73. Radzioch D, Kramnik I, Skamene E. Molecular mechanisms of natural resistance to mycobacterial infections. Circ Shock 1995; 44: 115-120.
74. Vidal S M, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993; 73: 469-485.